TriNetX Summit 2022

The TriNetX Summit commenced on the evening of Monday, October 17th with a welcome reception and exhibition featuring 100+ healthcare organizations from 26 countries and 25+ life sciences companies.

TriNetX’s chief executive officer discusses the mission of the company and the journey healthcare organizations and life sciences companies have taken to discover the possibilities of real-world data ‘for all mankind.’ Lachman highlights key achievements and growth since the prior Summit and unveils the acquisition of European regulatory-grade real-world evidence leader OncologyInformationService e.K. (OIS) and its subsidiary CancerDataNet GmbH.

Watch Recording

It all started with a mission to advance medicine and save lives, but on that journey, we discovered so much more. Hear TriNetX leaders share the latest product developments, the growth in depth and breadth of real-world data powering TriNetX technology, and the evolution of the TriNetX platform from 2019 to present.

Watch Recording

Real-world data is growing in importance for regulatory decision-making. This discussion will centralize on lessons learned from thought leaders working with regulatory agencies and the opportunities that lie ahead for assessment of data sources, fit-for-purpose, and transparency for internal decision-making and regulatory submissions. Learn how decision-makers are increasing their trust in proxies when complete verification of real-world data definitions is infeasible, and in what circumstances they are most applicable.

Watch Recording

As real-world data has exploded, so has data analysis. The need to identify, license, stage, and explore custom fit data along a fast and collaborative workflow has never been greater. But it’s remained a gap in our field, until now. LUCID is our new data science environment for coding, visualizing, and collaborating, equipped with the full range of features you’ve come to expect from today’s “data notebook” experiences. Best of all, LUCID is seamlessly connected to our LIVE networks, so you can build your cohort and stage the underlying data in a single end-to-end process. Learn how to reduce your “time to evidence” from months to days, even hours. Following a demo, we’ll hear from our regulatory, HEOR and market access leadership on how this streamlined path to real-world evidence could impact everything from submissions to payor negotiations.

Watch Recording

Watch Recording

Generating real-world evidence for peer-reviewed publication is of paramount importance to the TriNetX community. In this session, you will attain guidance on the use of TriNetX real-world data for this purpose, as well as hear from three researchers who presented studies that were successfully published utilizing the TriNetX platform and data.

Watch Recording

Diversity is a moral and scientific issue in clinical research. Hear members of the TriNetX community discuss the importance and efforts undertaken to reduce bias, promote social equity and empowerment, and produce innovative science informed by a representative population of patients that will ultimately receive treatment.

Watch Recording

Cancer touches everyone, and real-world data fuels innovation. However, in oncology real-world data is abundant yet disjointed and complex. Hear oncology experts from across the TriNetX community as they brainstorm ideas to improve our collective understanding and use of real-world data to support patients on their cancer journey.

Watch Recording

Thanks to the global TriNetX community, we can all study real-world data that is recent, a mile wide, and a mile deep. This session explores innovative applications of real-world data to improve patient safety, machine learning and predictive modeling for the early detection of patients at risk for developing pancreatic cancer, and the usefulness of prospective monitoring and following of cohorts to understand outcomes on a go forward basis.

Watch Recording

Clinical trials and chart reviews might appear to be an unlikely pairing; however they share commonalities for the TriNetX community. Pharmaceutical companies utilize the TriNetX platform and real-world data to collaborate with healthcare organizations that have eligible patients for both clinical trial and chart review opportunities. Hear thought leaders from both sides as they discuss opportunities to improve execution and collaboration across these studies.

Watch Recording